Cancer: Evidence Consistent with Epigenetic Carcinogenesis
- Authors
-
-
Patrick A. Riley
Totteridge Institute for Advanced Studies, London N20 8AB, UK
-
- Keywords:
- Malignant phenotype, abnormal transmigration, gene silencing, DNA methylation, defective epigenetic copying, initiation, promotion
- Abstract
-
This brief review outlines the accumulated evidence which favours a mechanism of cancer generation that is dependent on defective vertical transmission of the pattern of epigenetic control of genetic expression. This model is based on the initiating lesion involving the process that copies the epigenetic features when stem cells undergo mitosis.
- Downloads
-
Download data is not yet available.
- References
-
Riley PA. Epigenetic carcinogenesis and genetic instability: competitive aspects of the malignant phenotype. J Mol Oncol Res 2018; 2: 1-3. https://doi.org/10.35841/molecular-oncology.2.2.42-44
Riley PA. Cellular proliferative domains: barriers to migration. Cancer Nature 2018; 1: 1-2. https://doi.org/10.24983/scitemed.cn.2018.00079
Bradley A, Evans M, Kaufman MH, Robertson E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984; 309: 255-256. https://doi.org/10.1038/309255a0
Boddington MM, Spriggs AI. Cytological diagnosis of cancer: Its uses and limitations. Brit Med J 1965; 5449: 1523-1529. https://doi.org/10.1136/bmj.1.5449.1523
Riley PA. Is the initial event in carcinogenesis an enhancement of the mutation rate? Free Rad Res Comms 1990; 11: 59-63. https://doi.org/10.3109/10715769009109668
Burnet FM. Immunological Surveillance. Pergamon Press. Oxford UK 1970. https://doi.org/10.1016/B978-0-08-017481-5.50012-2
Riley PA. Failure of fidelity of vertical transmission of epigenetic patterning as the basis of cancer. Melanoma Res 2014; 24: 424-427. https://doi.org/10.1097/CMR.0000000000000100
Riley PA. Cancer is the outcome of defective epigeneic copying of the pattern of selective gene activity in differentiated cells. Canc Res Frontiers 2015; 1: 280-287. https://doi.org/10.17980/2015.280
Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science 1975; 187: 226-232. https://doi.org/10.1126/science.187.4173.226
Riggs AD. X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet 1975; 14: 9-25. https://doi.org/10.1159/000130315
Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389: 251-260. https://doi.org/10.1038/38444
Margueron R, Reinberg D. Chroatin structure and the inheritance of epigenetic information. Nat Rev Genet 2010; 11: 285-296. https://doi.org/10.1038/nrg2752
Wigler M, Levy D, Perucho M. The somatic replication of DNA methylation. Cell 1981; 24: 33-40. https://doi.org/10.1016/0092-8674(81)90498-0
Jones PA, Liang G. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 2009; 10: 805-811. https://doi.org/10.1038/nrg2651
Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet 2010; 11: 204-220. https://doi.org/10.1038/nrg2719
Levene AJ, Greenbaum B. Maintenance of epigenetic states by p53: The guardian of the epigenome. Oncotarget 2012; 3: 1503-1504. https://doi.org/10.18632/oncotarget.780
Riley PA. The epigenetic theory of carcinogenesis: p53 as the guardian of the epigenome. J Oncol Cancer Res 2017; 1: 1-6. https://doi.org/10.28967/jocr.2017.01.17002
Muller PAJ, Vousden KH. p53 mutations in cancer. Nature Cell Biol 2013; 15: 2-8. https://doi.org/10.1038/ncb2641
Riley PA. Epigenetic error and large-scale genomic instability in cancer. Biomed J Sci Tech Res 2018; 2018: 4. https://doi.org/10.26717/BJSTR.2018.04.0001057
Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1,3a,and 3b during the G0/G1 to s phase transition in normal and tumor cells. Nucleic Acids Res 2000; 28: 2108-2113. https://doi.org/10.1093/nar/28.10.2108
Riley PA. Cancer incidence in relation to species size: The Peto paradox in the light of the theory of epigenetic carcinogenesis. J Med Oncol 2018; 1: 11-14. https://doi.org/10.32907/RO-105-1417
Arrmitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Brit J Canc 1954; 8: 1-12. https://doi.org/10.1038/bjc.1954.1
Riley PA. Epigenetic theory of carcinogenesis: Investigation of the model of age-specific incidence. PRAS 2017; 1: 14-19.
Tomasetti C, Vogelstein B. Cancer etiology: Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 2015; 347: 78-81. https://doi.org/10.1126/science.1260825
Frank SA. Dynamics of cancer: Incidence, inheritance and evolution. Prineton University Press, Princeton NJ 2007. https://doi.org/10.1515/9780691186863
Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. L Natl Canc Inst 2000; 92: 328-332. https://doi.org/10.1093/jnci/92.4.328
Pompei F, Wilson R. Age-distribution of cancer: the incidence turnover at old age. Hum Ecol Risk Assess 2001; 7: 1619-1650. https://doi.org/10.1080/20018091095267
- Downloads
- Published
- 10-10-2022
- Issue
- Vol. 11 (2022)
- Section
- Articles
- License
-

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Patrick A. Riley, Epigenetic Carcinogenesis and Malignancy: The Significance of Migratory Potential , Journal of Cancer Research Updates: Vol. 12 (2023)
- Lydia Hopp, Edith Willscher, Henry Löffler-Wirth, Hans Binder, Function Shapes Content: DNA-Methylation Marker Genes and their Impact for Molecular Mechanisms of Glioma , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Sandip K. Mishra, K. Kanchan, Dharmendra K. Bhargava, A Review on EZH2 and its Epigenetic Association with Breast Cancer , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Amy Zhong, Melissa Chang, Theresa Yu, Raymond Gau, Daniel J. Riley, Yumay Chen, Phang-Lang Chen, Aberrant DNA Damage Response and DNA Repair Pathway in High Glucose Conditions , Journal of Cancer Research Updates: Vol. 7 No. 3 (2018)
- Sisir Nandi, Manish C. Bagchi, EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
- Hossein Mozdarani, Zainab Kouchak Mashkdouz, The Potent Regulatory Role of Circular RNAs in Breast Cancer Development, Diagnosis and Treatment: An Update , Journal of Cancer Research Updates: Vol. 11 (2022)
- Sisir Nandi, Manish C. Bagchi, Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer , Journal of Cancer Research Updates: Vol. 11 (2022)
- Parvin Mehdipour, Multi-Phase Based Signature and Cancer Management: An Insight in Embryo, Brain Tumor, Leukemia, and Von Hippel Lindau Syndrome , Journal of Cancer Research Updates: Vol. 12 (2023)
- Wifaq Siam, Mona Ellaithi, Hind M. AbuShama, Abdulrahman Mujalli, Shakir Idris, Alaa Siddiq, Osama Mohamed Khair, Dania A. Albader, Faris M. Elmahdi, Clinicopathological Features and RB1 Gene Polymorphism in Sudanese Retinoblastoma Patients , Journal of Cancer Research Updates: Vol. 14 (2025)
- Parvin Mehdipour, Asaad Azarnezha, Eight-Hit Evolutionary Pattern in ATM Gene of a Breast Carcinoma Patient: A Personalized Approach , Journal of Cancer Research Updates: Vol. 10 (2021)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Patrick A. Riley, Epigenetic Carcinogenesis and Malignancy: The Significance of Migratory Potential , Journal of Cancer Research Updates: Vol. 12 (2023)
